Form D Explorer

Inspect source fieldsReport a record issue

Form D — Pelthos Therapeutics Inc.

0001919246-26-000142 · filed Nov 16, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$57,500,000
Reported amount sold
$57,500,000
Minimum investment
$0
Investors
7
Sales commission
$0
Finders' fees
$0

Issuer

Name
Pelthos Therapeutics Inc.
CIK
1919246
Entity
Corporation
Jurisdiction
NEVADA
Year incorporated
2021
Address
4020 Stirrup Creek Drive, Suite 110
Durham, North Carolina 27703
Phone
919-908-2400

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗